Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,175,896
-
Share change
-
+704,898
-
Total reported value
-
$523,888,375
-
Put/Call ratio
-
160%
-
Price per share
-
$13.72
-
Number of holders
-
118
-
Value change
-
-$18,520,051
-
Number of buys
-
71
-
Number of sells
-
61
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q2 2016
As of 30 Jun 2016 CLOVIS ONCOLOGY INC - COM (CLVSQ) had 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,175,896 shares of stock of the company.
Largest 10 holders included Palo Alto Investors, LLC, Redmile Group, LLC, Consonance Capital Management LP, HealthCor Management, L.P., VANGUARD GROUP INC, PointState Capital LP, Partner Fund Management, L.P., GOLDMAN SACHS GROUP INC, STATE STREET CORP, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 118 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.